Cellectar Biosciences, Inc. (CLRB) Form S-1/A — May 29, 2026
Cellectar Biosciences (CLRB) filed an amended S-1 registration statement to register the resale of up to 51,998,413 shares of common stock by selling stockholders. These shares originate from a private placement and registered direct offering closed in May 2026, including shares underlying pre-funded warrants and Series A, B, and C warrants exercisable at $2.65 per share.
Key figures
- Cash Position
- 13200000
- Offering Price
- 2.65
- Shares Offered
- 51998413
- Shares Outstanding
- 57856595
- Rdo shares issued
- 1618053
- Last reported price
- 3.14
- Series a warrants shares
- 13206026
- Series b warrants shares
- 13206026
- Series c warrants shares
- 13206026
- Pre funded warrants shares
- 9471086
- Placement agent fee percent
- 8
- Placement agent warrants shares
- 792362
- Placement agent expense reimbursement
- 110000
Price after filing
1 day: 0.0%7 days: -12.4%30 days: -21.3%
Close on the filing date to close N calendar days later (from $3.14). Historical, not a forecast.
AI analysis
Red flags5 · Pro
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.